Control of telomere length by the human telomeric protein TRF1
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Human telomeres, the nucleoprotein complexes at chromosome ends, consist of tandem arrays of TTAGGG repeats bound to specific proteins. In normal human cells, telomeres shorten with successive cell divisions, probably due to the terminal sequence loss that accompanies DNA replication. In tumours and immortalized cells, this decline is halted through the activation of telomerase, a reverse transcriptase that extends the telomeric TTAGGG-repeat arrays. Telomere length is stable in several immortal human-cell lines, suggesting that a regulatory mechanism exists for limiting telomere elongation by telomerase. Here we show that the human telomeric-repeat binding factor TRF1 (ref. 8) is involved in this regulation. Long-term overexpression of TRF1 in the telomerase-positive tumour-cell line HT1080 resulted in a gradual and progressive telomere shortening. Conversely, telomere elongation was induced by expression of a dominant-negative TRF1 mutant that inhibited binding of endogenous TRF1 to telomeres. Our results identify TRF1 as a suppressor of telomere elongation and indicate that TRF1 is involved in the negative feedback mechanism that stabilizes telomere length. As TRF1 does not detectably affect the expression of telomerase, we propose that the binding of TRF1 controls telomere length in cis by inhibiting the action of telomerase at the ends of individual telomeres.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TRF1 can serve to modulate telomere length, but it also serves to facilitate DNA replication through the telomere repeats, which acts as fragile DNA sites (5)(6)(7).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [5]
In the citing paper
“TRF1 and TRF2 bind the double-stranded telomere.”
From Telomeres and telomerase in cancer (2010) · cites this paper as van Steensel,B. et al. (1997)
In the citing paper
“Telomere length in human cells is controlled by a homeostasis mechanism that involves telomerase and the negative regulator of telomere length, TRF1 (TTAGGG repeat binding factor 1).”
From Control of Human Telomere Length by TRF1 and TRF2 (2000) · cites this paper as [44]
In the citing paper
“In this system, TRF1 did not affect the activity of telomerase detectable in cell extracts, suggesting that TRF1 does not affect telomerase activity globally in the cell.”
From Control of Human Telomere Length by TRF1 and TRF2 (2000) · cites this paper as [44]
In the citing paper
“Conversely, the expression of a dominant negative allele of TRF1, which removes endogenous TRF1 from telomeres, leads to telomere elongation.”
From Control of Human Telomere Length by TRF1 and TRF2 (2000) · cites this paper as [44]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
Morin, G. B. (1989) · Cell · doi:10.1016/0092-8674(89)90035-4 · Cited by 1,495
Structure and variability of human chromosome ends.
de Lange, T., Shiue, L., Myers, R. M., Cox, D. R., Naylor, S. L., Killery, A. M., & Varmus, H. E. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.518 · Cited by 848
Progress towards a quantitative understanding of Antarctic ozone depletion
Solomon, S. (1990) · Nature · doi:10.1038/347347a0 · Cited by 734
Chong, L., van Steensel, B., Broccoli, D., Erdjument-Bromage, H., Hanish, J., Tempst, P., & de Lange, T. (1995) · Science · doi:10.1126/science.270.5242.1663 · Cited by 694
Cited by
Items 101–200 of 1,000
Kaminker, P. G., Kim, S.-H., Taylor, R. D., Zebarjadian, Y., Funk, W. D., Morin, G. B., Yaswen, P., & Campisi, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105968200 · Cited by 218
Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres
Espejel, S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2207 · Cited by 217
Progressive cis-inhibition of telomerase upon telomere elongation
Marcand, S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.12.3509 · Cited by 216
Silverman, J., Takai, H., Buonomo, S. B. C., Eisenhaber, F., & de Lange, T. (2004) · Genes & Development · doi:10.1101/gad.1216004 · Cited by 207
TRF1 binds a bipartite telomeric site with extreme spatial flexibility
Bianchi, A., Stansel, R. M., Fairall, L., Griffith, J. D., Rhodes, D., & de Lange, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5735 · Cited by 217
“…fact, efficient DNA binding in vitro by the dimeric protein appears to require the presence of two Myb domains in the dimer (Bianchi et al., 1997), and so does the telomeric localization of the protein in vivo (van Steensel and de Lange, 1997; A.Bianchi, H.Moss and T.de Lange, unpublished results).”
BackgroundStewart, J. A., Chaiken, M. F., Wang, F., & Price, C. M. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.08.011 · Cited by 209
“Overexpression of TRF1 and TRF2 leads to telomere shortening, suggesting that increased packaging of the telomere duplex by shelterin makes the DNA terminus less accessible, perhaps by promoting formation of t-loops or other higher order chromatin structures [124,125].”
Ancelin, K., Brunori, M., Bauwens, S., Koering, C.-E., Brun, C., Ricoul, M., Pommier, J.-P., Sabatier, L., & Gilson, E. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3474-3487.2002 · Cited by 205
“Reminiscent of the properties of the yeast Rap1p protein, an excess of TRF1 and TRF2 inhibits telomere elongation (69, 75).”
BackgroundThe Apollo 5′ Exonuclease Functions Together with TRF2 to Protect Telomeres from DNA Repair
Lenain, C., Bauwens, S., Amiard, S., Brunori, M., Giraud-Panis, M.-J., & Gilson, E. (2006) · Current Biology · doi:10.1016/j.cub.2006.05.021 · Cited by 198
Human Protection of Telomeres 1 (POT1) Is a Negative Regulator of Telomerase Activity In Vitro
Kelleher, C., Kurth, I., & Lingner, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.2.808-818.2005 · Cited by 211
“In humans, TRF1 appears to regulate telomere length through a similar counting mechanism (1, 37).”
BackgroundPOT1 Stimulates RecQ Helicases WRN and BLM to Unwind Telomeric DNA Substrates
Opresko, P. L., Mason, P. A., Podell, E. R., Lei, M., Hickson, I. D., Cech, T. R., & Bohr, V. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505211200 · Cited by 202
Stavropoulos, D. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.25.3135 · Cited by 197
“Immunostaining was carried out as described previously (54).”
MethodTelomeric Strategies: Means to an End
Jain, D., & Cooper, J. P. (2010) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134841 · Cited by 196
“TRF1 overexpression results in shortened telomeres, whereas overexpression of a dominant negative allele of TRF1 results in telomere elongation (199).”
BackgroundRole of Telomerase in Normal and Cancer Cells
Meyerson, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2626 · Cited by 204
TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere length control complex
Ye, J. Z.-S., & de Lange, T. (2004) · Nature Genetics · doi:10.1038/ng1360 · Cited by 197
TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres
Chang, W., Dynek, J. N., & Smith, S. (2003) · Genes & Development · doi:10.1101/gad.1077103 · Cited by 202
“Transient transfections and indirect immunofluorescence HelaI.2.11 cells (van Steensel et al. 1998) were transfected for 24 h with pMT123 (encoding HA-ubiquitin; Treier et al. 1994) or pcDNA3-FNtankyrase1.”
BackgroundMethodInfluentialSmith, S., & de Lange, T. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.21.3649 · Cited by 202
Dantzer, F., Giraud-Panis, M.-J., Jaco, I., Amé, J.-C., Schultz, I., Blasco, M., Koering, C.-E., Gilson, E., Ménissier-de Murcia, J., de Murcia, G., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1595-1607.2004 · Cited by 186
“activity is globally not affected (55, 59).”
Characterization of Oxidative Guanine Damage and Repair in Mammalian Telomeres
Wang, Z., Rhee, D. B., Lu, J., Bohr, C. T., Zhou, F., Vallabhaneni, H., de Souza-Pinto, N. C., & Liu, Y. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000951 · Cited by 195
A Major Role for the Plasmodium falciparum ApiAP2 Protein PfSIP2 in Chromosome End Biology
Flueck, C., Bartfai, R., Niederwieser, I., Witmer, K., Alako, B. T. F., Moes, S., Bozdech, Z., Jenoe, P., Stunnenberg, H. G., & Voss, T. S. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000784 · Cited by 184
“heterochromatin formation in yeasts and humans, respectively [2,59–64], specific DNA-protein interactions in TAS are hardly known and have only been investigated in detail in S.”
BackgroundThe role of stem cells in aging
Van Zant, G., & Liang, Y. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00088-2 · Cited by 195
“Although the length of telomeres at chromosome ends is important in maintaining genomic stability, it is increasingly clear that telomeres are also the substrate for the binding and interaction of multiple proteins, including TRF1 [147], TRF2 [148], and Ku [149], that, together with the tertiary loop structure of telo…”
BackgroundCanudas, S., & Smith, S. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200903096 · Cited by 186
Shelterin complex and associated factors at human telomeres
Diotti, R., & Loayza, D. (2011) · Nucleus · doi:10.4161/nucl.2.2.15135 · Cited by 187
“Both TRF1 and TRF2 are able to impose a restraint on telomerase, thereby restricting or inhibiting telomere elongation.(24,25) In addition, POT1 possesses a single telomeric overhang binding domain in its N-terminus,(20) which defines an activity essential for the inhibition of telomerase in cis.”
BackgroundChromosome ends: all the same under their caps
Pryde, F. E., Gorham, H. C., & Louis, E. J. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80046-9 · Cited by 187
Albanell, J., Engelhardt, M., Han, W., Moore, M. A. S., Lonardo, F., Rusch, V., Langenfeld, J., Klimstra, D., Venkatraman, E., & Dmitrovsky, E. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.21.1609 · Cited by 193
The Human Rap1 Protein Complex and Modulation of Telomere Length
O'Connor, M. S., Safari, A., Liu, D., Qin, J., & Songyang, Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312913200 · Cited by 182
Telomeres and senescence: The history, the experiment, the future
Greider, C. W. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70105-8 · Cited by 191
“Although this was the result that many had hoped for, recent evidence suggested that the availability of telomere-binding proteins might limit telomere growth [29].”
POT1 and TRF2 Cooperate To Maintain Telomeric Integrity
Yang, Q., Zheng, Y.-L., & Harris, C. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1070-1080.2005 · Cited by 182
“Using indirect immunofluorescence with TRF1, which is a specific marker for interphase telomeres (10, 46, 51), we showed that POT1 colocalized with TRF1 and TRF2 in the nuclei of IMR90 cells (Fig.”
The Individual Blood Cell Telomere Attrition Rate Is Telomere Length Dependent
Nordfjäll, K., Svenson, U., Norrback, K.-F., Adolfsson, R., Lenner, P., & Roos, G. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000375 · Cited by 184
Gcn5 and SAGA Regulate Shelterin Protein Turnover and Telomere Maintenance
Atanassov, B. S., Evrard, Y. A., Multani, A. S., Zhang, Z., Tora, L., Devys, D., Chang, S., & Dent, S. Y. R. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.015 · Cited by 180
Koering, C. E., Pollice, A., Zibella, M. P., Bauwens, S., Puisieux, A., Brunori, M., Brun, C., Martins, L., Sabatier, L., Pulitzer, J. F., et al. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf215 · Cited by 177
“Indeed, overexpression of full-length TRF1 leads to a relatively slow rate of shortening, ranging between 3 and 10 nt/MPD (van Steensel and de Lange, 1997), Alternatively, a small subset of cells could express TRF1-FLAG at a very high level, leading to a rapid telomere shortening in only a minority…”
BackgroundUhrbom, L., Hesselager, G., Östman, A., Nistér, M., & Westermark, B. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000201)85:3<407::aid-ijc18>3.0.co;2-8 · Cited by 85
Peptidyl-prolyl cis–trans isomerase Pin1 in ageing, cancer and Alzheimer disease
Lee, T. H., Pastorino, L., & Lu, K. P. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001906 · Cited by 181
DNA damage response at functional and dysfunctional telomeres
Longhese, M. P. (2008) · Genes & Development · doi:10.1101/gad.1626908 · Cited by 180
Rap1 Affects the Length and Heterogeneity of Human Telomeres
Li, B., & de Lange, T. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-06-0403 · Cited by 172
Targeted Deletion Reveals an Essential Function for the Telomere Length Regulator Trf1
Karlseder, J., Kachatrian, L., Takai, H., Mercer, K., Hingorani, S., Jacks, T., & de Lange, T. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.18.6533-6541.2003 · Cited by 178
“Functional studies have implicated human TRF1 (hTRF1) in telomere length homeostasis (52, 55).”
BackgroundInfluentialThe Fission Yeast Taz1 Protein Protects Chromosomes from Ku-Dependent End-to-End Fusions
Ferreira, M. G., & Cooper, J. P. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00154-x · Cited by 176
DNA Binding Features of Human POT1
Loayza, D., Parsons, H., Donigian, J., Hoke, K., & de Lange, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312309200 · Cited by 166
Telomere maintenance mechanisms and cellular immortalization
Colgin, L. M., & Reddel, R. R. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80014-8 · Cited by 176
Reprogramming of telomerase activity and rebuilding of telomere length in cloned cattle
Betts, D. H., Bordignon, V., Hill, J. R., Winger, Q., Westhusin, M. E., Smith, L. C., & King, W. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1077 · Cited by 161
The Catalytic Subunit of Telomerase Protects Neurons Against Amyloid β‐Peptide‐Induced Apoptosis
Zhu, H., Fu, W., & Mattson, M. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750117.x · Cited by 175
Chen, Z.-F., Qin, Q.-P., Qin, J.-L., Liu, Y.-C., Huang, K.-B., Li, Y.-L., Meng, T., Zhang, G.-H., Peng, Y., Luo, X.-J., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5012484 · Cited by 174
Neural stem cells and regulation of cell number
Sommer, L., & Rao, M. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00022-3 · Cited by 173
The molecular genetics of the telomere biology disorders
Bertuch, A. A. (2016) · RNA Biology · doi:10.1080/15476286.2015.1094596 · Cited by 169
“Finally, TRF1 is considered a negative regulator of telomerase.(37)”
BackgroundTelomere length measurement as a clinical biomarker of aging and disease
Fasching, C. L. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1504274 · Cited by 167
Protection of Telomeres by the Ku Protein in Fission Yeast
Baumann, P., & Cech, T. R. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.10.3265 · Cited by 167
Spallarossa, P., Altieri, P., Aloi, C., Garibaldi, S., Barisione, C., Ghigliotti, G., Fugazza, G., Barsotti, A., & Brunelli, C. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00068.2009 · Cited by 160
Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase
Kharbanda, S., Kumar, V., Dhar, S., Pandey, P., Chen, C., Majumder, P., Yuan, Z.-M., Whang, Y., Strauss, W., Pandita, T. K., et al. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00483-8 · Cited by 165
The Emerging Roles of TERRA in Telomere Maintenance and Genome Stability
Bettin, N., Oss Pegorar, C., & Cusanelli, E. (2019) · Cells · doi:10.3390/cells8030246 · Cited by 169
Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics
Seimiya, H., Muramatsu, Y., Ohishi, T., & Tsuruo, T. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.021 · Cited by 166
Grobelny, J. V., Godwin, A. K., & Broccoli, D. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.24.4577 · Cited by 165
Novel Nanosensors for Rapid Analysis of Telomerase Activity
Grimm, J., Perez, J. M., Josephson, L., & Weissleder, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2798 · Cited by 166
“Telomerase is a specialized reverse transcriptase, which is composed of an essential catalytic subunit and an RNA component (1–3) that, together with telomere-associated proteins, maintains telomere length and function (4, 5).”
BackgroundThe role of zinc in genomic stability
Sharif, R., Thomas, P., Zalewski, P., & Fenech, M. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.08.009 · Cited by 162
Prolyl isomerase Pin1: a promoter of cancer and a target for therapy
Chen, Y., Wu, Y., Yang, H., Li, X., Jie, M., Hu, C.-J., Wu, Y., Yang, S., & Yang, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0844-y · Cited by 173
ATM function and telomere stability
Pandita, T. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205060 · Cited by 164
Molecular and Genetic Aspects of Lung Cancer
ROM, W. N., HAY, J. G., LEE, T. C., JIANG, Y., & TCHOU-WONG, K.-M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.9908012 · Cited by 163
Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532
Eldaly, H., Kull, M., Zimmermann, S., Pantić, M., Waller, C. F., & Martens, U. M. (2004) · Blood · doi:10.1182/blood-2003-12-4322 · Cited by 171
Comparison between TRF2 and TRF1 of their telomeric DNA‐bound structures and DNA‐binding activities
Hanaoka, S., Nagadoi, A., & Nishimura, Y. (2005) · Protein Science · doi:10.1110/ps.04983705 · Cited by 146
Regulation of Telomere Length and Telomerase in T and B Cells
Weng, N., Hathcock, K. S., & Hodes, R. J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80597-x · Cited by 173
Mayer, S., Brüderlein, S., Perner, S., Waibel, I., Holdenried, A., Ciloglu, N., Hasel, C., Mattfeldt, T., Nielsen, K. V., & Möller, P. (2006) · Cytogenetic and Genome Research · doi:10.1159/000089870 · Cited by 148
Mammalian Meiotic Telomeres: Protein Composition and Redistribution in Relation to Nuclear Pores
Scherthan, H., Jerratsch, M., Li, B., Smith, S. H., Hultén, M. A., Lock, T., & de Lange, T. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4189 · Cited by 162
Telomere structure and telomerase in health and disease
GOMEZ, D. E., ARMANDO, R. G., FARINA, H. G., MENNA, P. L., CERRUDO, C. S., GHIRINGHELLI, P. D., & ALONSO, D. F. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1611 · Cited by 145
“TRF2 has unique functions in the telomere as stabilizer of the protruding G string and is able to prevent telomeric fusions (19).”
BackgroundOh, B.-K., Kim, Y., Park, C., & Park, Y. N. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62233-x · Cited by 155
TRF2 and lamin A/C interact to facilitate the functional organization of chromosome ends
Wood, A. M., Danielsen, J. M. R., Lucas, C. A., Rice, E. L., Scalzo, D., Shimi, T., Goldman, R. D., Smith, E. D., Le Beau, M. M., & Kosak, S. T. (2014) · Nature Communications · doi:10.1038/ncomms6467 · Cited by 142
Closed chromatin loops at the ends of chromosomes
Nikitina, T., & Woodcock, C. L. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403118 · Cited by 147
Jha, K. K., Banga, S. S., Palejwala, V. A., & Ozer, H. L. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4272 · Cited by 181
Impact of oxidative stress on telomere biology
Ahmed, W., & Lingner, J. (2018) · Differentiation · doi:10.1016/j.diff.2017.12.002 · Cited by 153
Patry, C., Bouchard, L., Labrecque, P., Gendron, D., Lemieux, B., Toutant, J., Lapointe, E., Wellinger, R. J., & Chabot, B. (2003) · PubMed · Cited by 173
NuMA is a major acceptor of poly(ADP-ribosyl)ation by tankyrase 1 in mitosis
Chang, W., Dynek, J. N., & Smith, S. H. (2005) · Biochemical Journal · doi:10.1042/bj20050885 · Cited by 171
“Tankyrase 1 was initially identified in a two-hybrid screen with the telomeric TTAGGG-repeat binding protein TRF1 (telomeric repeat binding factor 1) [8], a negative regulator of telomere length that acts in cis to block access of telomerase to telomeres [9, 10 ].”
BackgroundLoss of hPot1 Function Leads to Telomere Instability and a cut-like Phenotype
Veldman, T., Etheridge, K. T., & Counter, C. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.12.031 · Cited by 151
Developmental Control of Telomere Lengths and Telomerase Activity in Plants
Říha, K., Fajkus, J., Široký, J., & Vyskot, B. (1998) · The Plant Cell · doi:10.1105/tpc.10.10.1691 · Cited by 158
“The human telomere binding protein TRF1 acts as a negative regulator of human telomerase (van Steensel and de Lange, 1997).”
Human telomeric proteins occupy selective interstitial sites
Yang, D., Xiong, Y., Kim, H., He, Q., Li, Y., Chen, R., & Songyang, Z. (2011) · Cell Research · doi:10.1038/cr.2011.39 · Cited by 161
Functionally interacting telomerase RNAs in the yeast telomerase complex
Prescott, J., & Blackburn, E. H. (1997) · Genes & Development · doi:10.1101/gad.11.21.2790 · Cited by 150
TRF1 promotes parallel pairing of telomeric tracts in vitro
Griffith, J., Bianchi, A., & de Lange, T. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1686 · Cited by 148
Gavia-García, G., Rosado-Pérez, J., Arista-Ugalde, T. L., Aguíñiga-Sánchez, I., Santiago‐Osorio, E., & Mendoza-Núñez, V. M. (2021) · Biology · doi:10.3390/biology10040253 · Cited by 167
Telomeres, telomerase, and myc. An update
Cerni, C. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(99)00091-5 · Cited by 162
Differential regulation of telomerase activity and TERT expression during brain development in mice
Klapper, W., Shin, T., & Mattson, M. P. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1073 · Cited by 146
Seimiya, H., & Smith, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112266200 · Cited by 147
The Polar Arrangement of Telomeres in Interphase and Meiosis. Rabl Organization and the Bouquet
Cowan, C. R., Carlton, P. M., & Cande, W. Z. (2001) · PLANT PHYSIOLOGY · doi:10.1104/pp.125.2.532 · Cited by 147
Tomita, K., Matsuura, A., Caspari, T., Carr, A. M., Akamatsu, Y., Iwasaki, H., Mizuno, K.-I., Ohta, K., Uritani, M., Ushimaru, T., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5186-5197.2003 · Cited by 148
Ebersole, T. A. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.11.1623 · Cited by 147
Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors
Tentori, L., Portarena, I., & Graziani, G. (2002) · Pharmacological Research · doi:10.1006/phrs.2001.0935 · Cited by 155
Telomerase activation, cellular immortalization and cancer
Hahn, W. C., & Meyerson, M. (2001) · Annals of Medicine · doi:10.3109/07853890109002067 · Cited by 142
Voghel, G., Thorin‐Trescases, N., Farhat, N., Nguyen, A. Q., Villeneuve, L. R., Mamarbachi, A. M., Fortier, A., Perrault, L. P., Carrier, M., & Thorin, É. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.09.006 · Cited by 158
Toouli, C. D., Huschtscha, L. I., Neumann, A. A., Noble, J. R., Colgin, L. M., Hukku, B., & Reddel, R. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205014 · Cited by 125
Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer
Hahn, W. C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.018 · Cited by 143
Telomeric Proteins Regulate Episomal Maintenance of Epstein-Barr Virus Origin of Plasmid Replication
Deng, Z., Lezina, L., Chen, C., Shtivelband, S., So, W., & Lieberman, P. M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00476-8 · Cited by 154
Telomere length regulation: coupling DNA end processing to feedback regulation of telomerase
Shore, D., & Bianchi, A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.195 · Cited by 137
Genomic footprints of activated telomere maintenance mechanisms in cancer
Sieverling, L., Hong, C., Koser, S. D., Ginsbach, P., Kleinheinz, K., Hutter, B., Braun, D. M., Cortés‐Ciriano, I., Xi, R., Kabbe, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13824-9 · Cited by 158
Bundock, P., & Hooykaas, P. (2002) · The Plant Cell · doi:10.1105/tpc.005959 · Cited by 136
T cells and aging update February 1999
Pawelec, G. (1999) · Frontiers in Bioscience · doi:10.2741/a424 · Cited by 139
“They also suggest that ways of manipulating telomere length may be applicable therapeutically in this and other contexts (60,61).”
Telomeres, sex, reactive oxygen species, and human cardiovascular aging
Aviv, A. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0377-8 · Cited by 138
“trition is modified by the telomeric binding proteins TRF1 and TRF2, which accelerate telomere attrition [14, 18, 19] and by the activity of a reverse transcriptase, tel-”
BackgroundATM and ATR Signaling Regulate the Recruitment of Human Telomerase to Telomeres
Tong, A. S., Stern, J. L., Sfeir, A., Kartawinata, M., de Lange, T., Zhu, X.-D., & Bryan, T. M. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.041 · Cited by 142
Human Sperm Telomere–Binding Complex Involves Histone H2b and Secures Telomere Membrane Attachment
Gineitis, A. A., Zalenskaya, I. A., Yau, P. M., Bradbury, E. M., & Zalensky, A. O. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.7.1591 · Cited by 130
E2F-1 represses transcription of the human telomerase reverse transcriptase gene
Crowe, D. L. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.13.2789 · Cited by 135
Ducray, C., Pommier, J., Martins, L., Boussin, F. D., & Sabatier, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202797 · Cited by 149
Sbodio, J. I., Lodish, H. F., & Chi, N. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610451 · Cited by 137
Remarkable Differences in Telomere Lengths among Cloned Cattle Derived from Different Cell Types1
Miyashita, N., Shiga, K., YONAI, M., Kaneyama, K., Kobayashi, S., Kojima, T., Goto, Y., Kishi, M., Aso, H., Suzuki, T., et al. (2002) · Biology of Reproduction · doi:10.1095/biolreprod66.6.1649 · Cited by 137
“It may, instead, be partially explained by a possibility that donor cell type-specific sensitivities to telomerase, based on telomere-binding proteins [36, 37], lead to the difference in the extent of telomere elongation in reconstructed embryos.”
BackgroundRole of shelterin in cancer and aging
Martínez, P., & Blasco, M. A. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00596.x · Cited by 136
Extrachromosomal circular DNA: biogenesis, structure, functions and diseases
Yang, L., Jia, R., Ge, T., Ge, S., Zhuang, A., Chai, P., & Fan, X. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01176-8 · Cited by 156
Positive and negative regulation of telomerase access to the telomere
Evans, S. K., & Lundblad, V. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.19.3357 · Cited by 138
Metadata
- Authors
- van Steensel, B., & de Lange, T.
- Venue
- Nature
- Published
- 1997-02
- Volume
- 385
- Issue
- 6618
- Pages
- 740-743
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2086992094
- Semantic Scholar
- 080771c5a8e8b8bc6d55561a31326094194412ea
- Cited by
- 1,219
- References
- 30
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 26 · 2023: 27 · 2022: 13 · 2021: 35 · 2020: 25 · 2019: 25 · 2018: 28 · 2017: 32 · 2016: 30 · 2015: 28 · 2014: 44 · 2013: 37 · 2012: 32
- FWCI
- 43.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- TRF1, telomere length regulation, telomerase, telomere shortening, telomere elongation, telomere binding, negative feedback loop, cancer cells, immortalized cells, TTAGGG repeats
- MeSH terms
- DNA-Binding Proteins, Feedback, Genes, Dominant, HeLa Cells, Humans, Mutation, Recombinant Proteins, Tumor Cells, Cultured, Telomere, Telomerase, Telomeric Repeat Binding Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.